Corbus Pharmaceuticals
CRBP
#8618
Rank
S$0.23 B
Marketcap
S$13.46
Share price
1.27%
Change (1 day)
-34.16%
Change (1 year)

Operating Margin for Corbus Pharmaceuticals (CRBP)

Operating Margin as of December 2025 (TTM): -5,176.38%

According to Corbus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -5,176.38%. At the end of 2021 the company had an Operating Margin of -5,176.38%.

Operating Margin history for Corbus Pharmaceuticals from 2016 to 2021

Operating Margin at the end of each year

Year Operating Margin Change
2021-5,176.38%83.16%
2020-2,826.08%1329.52%
2019-197.69%-82.88%
2018-1,154.48%-13.11%
2017-1,328.65%26.99%
2016-1,046.27%-23.35%
2015-1,365.05%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Vanda Pharmaceuticals
VNDA
-57.09%-98.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Viking Therapeutics
VKTX
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS
-399,877.00% 7,625.03%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.